Bavarian Nordic announces commercial availability of mpox vaccine in US
Pharmaceutical Business Review
APRIL 3, 2024
The Centers for Disease Control and Prevention (CDC) had provided interim guidance for the vaccine’s pre- and post-exposure use during the outbreak for people at risk. The CDC estimates that two million individuals in the US are eligible for the mpox vaccination.
52 
Let's personalize your content